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Attenuated hypocholesterolemia following severe
trauma signals risk for late ventilator-associated
pneumonia, ventilator dependency, and death:
a retrospective study of consecutive patients
C Michael Dunham*, Thomas J Chirichella
Abstract
Background: Post-traumatic ventilator-associated pneumonia (VAP) is a substantial clinical problem that increases
hospital costs and typically adds to the duration of mechanical ventilation. We evaluated the impact of VAP on
ventilator days. We also assessed 48-hour total blood cholesterol (TC) and other potential risk factors for the
development of VAP.
Methods: We performed a retrospective study of consecutive trauma patients requiring emergency tracheal
intubation and evaluated TC, age, gender, ethanol status, smoker status, injury mechanism, chest injury, brain injury,
Injury Severity Score (ISS), shock, day-one hypoxemia, and RBC transfusion as potential risks for VAP.
Results: The 152 patients had ISS 28.1, brain injury 68.4%, VAP 50.0%, ventilator days 14.3, and death 9.9%.
Ventilator days were increased with late VAP (p < 0.0001). TC was 110.7 mg/dL with expected TC 197.5 mg/dL. TC
was lower with chest injury, shock, and RBC transfusion but, higher with brain injury (p ≤ 0.01). TC decreased as ISS
increased (p = 0.01). However, one patient subset (ISS ≥ 20-&-TC ≥ 90 mg/dL) had a relative increase in TC despite
an increase in ISS. ISS ≥ 20-&-TC ≥ 90 mg/dL, but not ISS alone, was the only independent predictor of late VAP
(OR 3.0; p = 0.002). ISS ≥ 20-&-TC ≥ 90 mg/dL and day-one hypoxemia were the only independent predictors for
increased ventilator days (p = 0.01). ISS ≥ 20-&-TC ≥ 90 mg/dL, but not ISS alone, was the only predictor of death
(OR 3.8; p = 0.03).
Conclusions: Severe traumatic injury produced substantial hypocholesterolemia that is greater with chest injury,
shock, and RBC transfusion, but less with brain injury. Total blood cholesterol tended to decrease with increasing
injury severity. However, attenuated hypocholesterolemia (ISS ≥ 20-&-TC ≥ 90 mg/dL) represents a unique response
that can occur with critical injury. Attenuated hypocholesterolemia signals early risk for late VAP, ventilator
dependency, and death.
Background
Ventilator-associated pneumonia (VAP) rates following
traumatic injury have been shown to be variable and
range from less than 20% [1,2] to as high as 40-60%
[2-5]. Of interest, some investigators have implied there
is a virtual elimination of posttraumatic VAP with the
implementation of ventilator bundle management [6].
However, other studies indicate that VAP rates with
traumatic brain injury are substantial, 32-45% [4,5]. Due
to postinjury pulmonary aspiration risk, VAP is likely to
continue as a vexing problem for institutions managing
patients with severe brain injury.
It is controversial whether VAP has an influence on
death. Some investigators have found that VAP
increases death, [2,5] while others did not. Studies
showing no impact on death include those with [7] and
without [4] control groups. Compellingly, numerous
trauma patient studies have demonstrated that VAP,
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when compared to non-VAP patients, prolongs the
duration of mechanical ventilation [4-7].
Investigators have shown that the inflammatory
response at 48 hours postinjury indicates the risk for
development of VAP. Woiciechowsky [8] showed that
subsequent VAP development relates to higher levels of
Interleukin-6, while Cohen [9] found a relationship with
plasma Protein C values.
Because multiple studies have implied that emergency
tracheal intubation in trauma patients increases VAP
rates, [1,2,7] we undertook a retrospective review of
consecutive trauma patients undergoing emergency tra-
cheal intubation. The primary purpose of the study was
to evaluate the impact of VAP on duration of mechani-
cal ventilation. The secondary objective was to assess
potential early risk factors, e.g., Injury Severity Score
(ISS) and smoking status, for the development of VAP.
Because the first author has published on total blood
cholesterol (TC) in other trauma populations, [10,11] we
monitor TC, an inflammatory marker, daily in our
intensive care unit (ICU). Based on the work by Woicie-
chowsky and Cohen, we selected 48-hour TC as a
potential risk factor for VAP. Since phenytoin can influ-
ence TC levels [12,13] and many patients undergoing
emergency tracheal intubation receive phenytoin for
severe brain injury, we evaluated the relationship
between 48-hour TC and phenytoin loading.
Methods
Study eligibility criteria were consecutive trauma
patients requiring emergency tracheal intubation within
24 hours of injury and mechanical ventilation for greater
than or equal two days. Early risk factor analysis for
VAP included the following variables: age, gender, etha-
nol status, smoking status, mechanism of injury, Injury
Severity Score (ISS), chest injury, brain injury, shock,
red blood cell (RBC) transfusion, day-one hypoxemia,
and 48-hour TC. A univariate statistical assessment was
performed for each potential risk factor and VAP. 48-
hour TC was then interacted with the other potential
risk factors to determine if there is a statistical relation-
ship with VAP. Information in the study database came
from a Level I Trauma Registry and, as needed, medical
record review. The Institutional Review Board waived
the need for informed consent.
The following statements provide clarification of study
methodology and variable definitions. Day-one hypoxe-
mia indicates a PaO2/FiO2 < 200 during the first 24
hours postinjury. VAP criteria included: 1) the presence
of two or more Systemic Inflammatory Response Syn-
drome (SIRS) criteria, 2) new or progressive radio-
graphic pulmonary infiltrate, and 3) a laboratory report
with a) moderate or abundant culture growth of a bac-
terial pathogen, or b) polymicrobial growth with
moderate or abundant polymorphonuclear white blood
cells on sputum gram stain. Sputum specimens were
harvested using bronchoscopic-directed or blind-aspira-
tion methods, without alveolar lavage. Using the Centers
for Disease Control criteria, early VAP occurs in the
first-48 hours postinjury, while late VAP takes place
after the first-48 hours. Mean Expected TC values were
from a large, United States, population-based survey,
according to gender and age range. Because pre-injury
TC values were not available, Expected TC served as a
relative reference for the postinjury TC values. Sources
for Expected TC emanated from the Centers for Disease
Control and Prevention using 2003-2006 data (GOO-
GLE search: “Health, United States, 2009"; see table 69)
and Arnett’s study [14] using 2000-2002 data. Fractional
TC is the 48-hour TC value divided by the Expected TC
value. The TC Difference is the expected TC value
minus the 48-hour TC value.
We identified which brain-injured patients underwent
phenytoin loading on the day of injury. Phenytoin load-
ing was documented when there is a written order and
validation in the medication administration record. Phe-
nytoin serum level results were assessed at 24-48 hours
after loading.
We used the SAS System for Windows, release 9.2
(SAS Institute Inc., Cary, NC, USA) to perform statisti-
cal analysis. We expressed continuous variables as mean
and standard deviation. We assessed statistical relation-
ships using the following techniques: a) t-test for com-
parison of interval continuous data between two groups;
b) Wilcoxon rank-sum test for comparison of ordinal-
rank continuous data between two groups; c) Pearson
correlation coefficient analysis to assess the relationship
between two continuous variables; d) Fisher’s exact test
to assess 2 × 2 contingency tables; e) multivariate
regression analysis to assess independent variable impact
on continuous response variables; and f) logistic multi-
variate regression analysis to assess independent variable
impact on binary response variables. We considered p <
0.05 to represent statistical significance.
Results
From August 2006 to June 2008, 152 consecutive
patients underwent 2,170 days of mechanical ventilation.
Traits of the study patients and outcomes are in Table
1. Of the 152 patients, 76 (50.0%) had VAP (early and/
or late). Early VAP without late VAP occurred in 19
patients, late VAP without early VAP occurred in 43
patients, and late VAP with early VAP occurred in 14
patients. The late VAP rate (without or with early VAP)
was 37.5% (57/152). After excluding the seven patients
dying in the first six days, the influence of VAP on
duration of mechanical ventilation was determined. Of
the 73 patients without VAP, the duration of ventilation
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was 11.1 ± 7.8 days. The 17 patients with early VAP, but
no late VAP underwent 12.3 ± 9.0 days of ventilation (p
= 0.54). The duration of mechanical ventilation for the
90 patients without late VAP was 11.4 ± 8.0 days,
whereas the 55 patients with late VAP had 20.3 ± 12.3
ventilator days (p < 0.0001).
The risk factor analysis demonstrated that age, gender,
ethanol status, smoker status, mechanism of injury,
chest injury, brain injury, shock, and day-one hypoxemia
rates and RBC transfusion amounts did not differ with-
out or with late VAP (p >> 0.05). ISS values were higher
in patients with late VAP (without or with early VAP)
(see Table 2). The interaction between ISS and TC
(ISS × TC) was higher with late VAP and created a
more significant relationship with late VAP than did ISS
alone (see Table 2). Using logistic regression analysis,
late VAP had an association with ISS × TC (p = 0.03),
but not ISS (p = 0.58). ISS was dichotomized into the
following groups: ≥ 15, ≥ 20, ≥ 25, and ≥ 30. The ISS ≥
20 dichotomy yielded the greatest accuracy and sensitiv-
ity for late VAP. The ISS and TC interaction was
dichotomized to evaluate its relationship with late VAP
(see Table 3). The ISS ≥ 20-&-TC ≥ 90 mg/dL dichot-
omy produced the best balance between accuracy and
sensitivity with late VAP. The late VAP rate with ISS ≥
20-&-TC ≥ 90 mg/dL was 48.8% (40/82) and in the
group without ISS ≥ 20-&-TC ≥ 90 mg/dL was 24.3%
(17/70). Using logistic regression analysis, late VAP had
an association with ISS ≥ 20-&-TC ≥ 90 mg/dL (p =
0.009), but not ISS (p = 0.27).
Patients with chest injury, shock, or RBC transfusion
had greater hypocholesterolemia (HC) than those with-
out these conditions (see Table 4). Brain injury patients
had less HC then those without brain injury (see Table
4). Of the 152 patients, 69 (45.4%) had phenytoin load-
ing with a therapeutic level in 66 (95.6%) at 24-48
hours. TC levels were higher with phenytoin loading
(115.7 ± 30.9) in comparison to those without loading
(106.5 ± 29.3; p = 0.06). Multivariate regression analysis
showed that TC levels relate to brain injury (p = 0.006),
but not phenytoin loading (p = 0.92).
Of the 57 late VAP patients, the mean 48-hour TC
was 114.3 ± 27.8. Subsequently, the late VAP TC mean
decreased to 94.5 ± 25.8; p = 0.0002. At discharge from
the ICU, the late VAP TC mean increased to 130.7 ±
45.1; p = 0.0001.
The ISS ≥ 20-&-TC ≥ 90 mg/dL group had a higher
ISS and 48-hour TC than the other group; see Table 5.
For the 152 patients, TC had a weak, inverse relation-
ship with ISS (r = -0.20; p = 0.01). With ISS ≥ 30, TC
was lower (102.9 ± 28.6 mg/dL) when compared to ISS
< 30 (115.9 ± 30.4 mg/dL; p = 0.009). The ISS ≥ 20-
&-TC ≥ 90 mg/dL group had no significant relationship
Table 1 Injury Characteristics and Outcomes of
Emergently Intubated Patients
Characteristic Data
Age (years) 42.5 ± 19
Male 113 (74.3%)
Ethanol Positive 48 (31.6%)
Smoker 53 (34.9%)
Blunt trauma 141 (92.8%)
ISS 28.1 ± 12.4
ISS ≥ 20 113 (74.3%)
Chest injury 72 (47.4%)
Head AIS 3.0 ± 2.0
Brain injury 104 (68.4%)
GCS 9.4 ± 4.5
GCS ≤ 8 74 (48.7%)
Shock 43 (28.3%)
RBC transfusion 53 (34.9%)
Day-one Hypoxemia 74 (48.7%)
VAP 76 (50.0%)
Expected TC (mg/dL) 197.5 ± 15.5
48-hour TC (mg/dL) 110.7 ± 30.3
Fractional TC 0.560 ± 0.15
TC Difference (mg/dL) 86.8 ± 29.5
Ventilator days 14.3 ± 10.7
ICU days 17.2 ± 10.5
Hospital LOS 20.4 ± 11.0
Death 15 (9.9%)
ISS, Injury Severity Score; AIS, Abbreviated Injury Scale; GCS, Glasgow Coma
Score; RBC, red blood cell; VAP, ventilator-associated pneumonia; TC, total
cholesterol; ICU, intensive care unit; LOS, length of stay.
Table 2 ISS ≥ 20 and TC ≥ 90 mg/dL is a Risk for Late
VAP
No LVAP LVAP P Value
Patients 95 (62.5%) 57 (37.5%)
48-hour TC (mg/dL) 108.6 ± 31.6 114.3 ± 27.8 0.26
ISS 26.5 ± 11.9 30.6 ± 13.0 0.048
ISS × TC 2762.4 ± 1243.7 3487.6 ± 1789.2 0.004
ISS, Injury Severity Score; TC, total cholesterol; VAP, ventilator-associated
pneumonia; LVAP, late VAP.
Table 3 Dichotomized ISS × 48-hour TC Relationship with
Late VAP



























53.9% 69.1% 80.7% 43.8% 2.6 0.02
ISS, Injury Severity Score; TC, total cholesterol; LVAP, late ventilatory-associated
pneumonia; PPV, positive predictive value; OR, odds ratio.
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between ISS and TC (n = 82; r = -0.07; p = 0.55). See
Figure 1 However, the other group had a significant
inverse association between ISS and TC (n = 70; r =
-0.53; p < 0.0001).
The mechanism of injury, chest injury, brain injury,
shock, day-one hypoxemia, VAP, late VAP rates, RBC
transfusion, ISS, and 48-hour TC did not differ in 137
surviving and 15 dying patients (p >> 0.05). However,
ISS × TC was higher in the deaths (3828.3 ± 1495.3)
when compared to the survivors (2947.4 ± 1489.2; p =
0.03). The ISS ≥ 20-&-TC ≥ 90 mg/dL rate was also
higher in those dying (80.0% [70/137]) when compared
to those living (51.1% [12/15]; OR = 3.8; p = 0.03). The
death rate with ISS ≥ 20-&-TC ≥ 90 mg/dL was 14.6%
(12/82) and the rate without ISS ≥ 20-&-TC ≥ 90 mg/
dL was 4.3% (3/70). The death and ISS ≥ 20-&-TC ≥ 90
mg/dL relationship had a sensitivity of 80.0%, positive
predictive value of 14.6%, negative predictive value of
95.7%, odds ratio of 3.8, and p = 0.03.
Further analysis excluded the seven patients dying dur-
ing the first 6 days. The remaining 145 patients accounted
for 95.4% of the patients. Of the 145 patients, 75 (51.7%)
had ISS ≥ 20-&-TC ≥ 90 mg/dL and 70 (48.3%) did not.
Late VAP occurred in 55 (37.9%). The potential early
predictors, age, gender, ethanol status, smoker status,
mechanism of injury, chest injury, brain injury, and shock
rates, RBC transfusion amounts, and 48-hour TC values
did not influence the duration of mechanical ventilation (p
>> 0.05). The duration of mechanical ventilation increased
with ISS (p = 0.03), day-one hypoxemia (p = 0.01), ISS ×
TC (p = 0.048), and ISS ≥ 20-&-TC ≥ 90 mg/dL (p =
0.02). Using multivariate regression analysis, duration of
mechanical ventilation had an association with day-one
hypoxemia (p = 0.01) and ISS ≥ 20-&-TC ≥ 90 mg/dL (p =
0.01), but not ISS (p = 0.19).
Discussion
The study group undergoing emergency tracheal intuba-
tion principally had blunt trauma, serious anatomic inju-
ries (according to ISS), and severe brain injury.
Outcomes included a VAP rate of 50%, two weeks of
mechanical ventilation, and a 10% death rate. Substantial
HC occurred at 48 hours postinjury and late VAP had an
association with increased days of mechanical ventilation.
Other investigators have also found significant HC fol-
lowing traumatic injury [10,11,15-17] and an increase in
ventilator days with VAP [4-7]. Of the numerous poten-
tial risk factors assessed, only the interactive variable, ISS
≥ 20-&-TC ≥ 90 mg/dL, had an independent association
with late VAP. ISS ≥ 20-&-TC ≥ 90 mg/dL also had a sig-
nificant relationship with increased mortality and dura-
tion of mechanical ventilation.
ISS ≥ 20-&-TC ≥ 90 mg/dL is a risk for late VAP, death,
and ventilator dependency
We found very few early, postinjury predictors for the
subsequent development of late VAP. Specifically, age,
gender, ethanol, smoker, mechanism of injury, chest
injury, brain injury, shock, RBC transfusion, and day-one
hypoxemia status were not risk factors for late VAP
(without or with early VAP). On the other hand, ISS, ISS
× TC, and ISS ≥ 20-&-TC ≥ 90 mg/dL were higher in
patients with late VAP. Of great interest, ISS × TC and
ISS ≥ 20-&-TC ≥ 90 mg/dL were independent predictors
of late VAP, whereas ISS was not. Thus, the interaction
of ISS and TC had a stronger association with late
VAP than did ISS alone. Accordingly, ISS ≥ 20-&-TC ≥
90 mg/dL signals an early jeopardy for late VAP and its
association with greater ventilator dependency.
Almost all potential early risk factors failed to differ in
surviving and dying patients. These variables included
blunt trauma mechanism, chest injury, brain injury,
shock, RBC transfusion, day-one hypoxemia, VAP, late
VAP, 48-hour TC, and ISS. However, the ISS-TC inter-
action variables (ISS × TC and ISS ≥ 20-&-TC ≥ 90 mg/
dL) were significantly greater for nonsurvivors.
Similar to the findings with late VAP and death, most
potential early risk factors failed to have an association
Table 4 48-hour Total Cholesterol Levels by Injury Traits
No Chest Injury Chest Injury P Value
Number 80 (52.6%) 72 (47.4%) –
TC (mg/dL) 119.8 ± 28.5 100.6 ± 29.1 0.0001
ISS 24.3 ± 12.0 32.3 ± 11.5 0.0001
No Shock Shock
Number 109 (71.7%) 43 (28.3%) –
TC (mg/dL) 114.5 ± 31.1 101.0 ± 26.1 0.01
ISS 26.4 ± 11.5 32.2 ± 13.7 0.01
No Transfusion Transfusion
Number 99 (65.1%) 53 (34.9%) –
TC (mg/dL) 121.2 ± 29.5 91.2 ± 20.6 0.0001
ISS 25.1 ± 12.5 33.6 ± 10.2 0.0001
No Brain Injury Brain Injury
Number 48 (31.6%) 104 (68.4%) –
TC (mg/dL) 98.8 ± 27.7 116.2 ± 30.0 0.0008
ISS 24.5 ± 14.4 29.7 ± 11.1 0.02
TC, total cholesterol; ISS, Injury Severity Score.
Table 5 ISS ≥ 20 and TC ≥ 90 mg/dL Traits
ISS ≥ 20-&-TC ≥ 90 mg/dL No Yes P Value
Number 70 82 –
48-hour TC (mg/dL) 99.3 ± 33.2 120.5 ± 23.6 0.0001
ISS 23.9 ± 13.3 31.7 ± 10.4 0.0001
ISS × TC 2140.4 ± 950.4 3797.5 ± 1479.8 0.0001
ISS, Injury Severity Score; TC, total cholesterol; RBC, red blood cell.
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with mechanical ventilation duration. However, the
duration of mechanical ventilation increased with ISS,
day-one hypoxemia, ISS × TC, and ISS ≥ 20-&-TC ≥ 90
mg/dL. Using multivariate regression analysis, ISS ≥ 20-
&-TC ≥ 90 mg/dL and day-one hypoxemia had an inde-
pendent significant relationship with ventilator days.
However, ISS did not have an independent effect with
day-one hypoxemia status. The multiple relationships of
ISS ≥ 20-&-TC ≥ 90 mg/dL with late VAP, death, and
days of mechanical ventilation imply that the interaction
of ISS with 48-hour TC has a greater association than
ISS alone.
Factors influencing hypocholesterolemia
A comparison of the 48-hour TC values with the
expected levels (Fractional TC and TC Difference), from
a large population-based survey, provides a perspective
for the magnitude of HC. This evaluation showed a
reduction of 48-hour postinjury TC to be almost 50% of
the expected levels, with a decrement in TC near 90
mg/dL. Others have also found substantial HC following
traumatic injury [10,11,15-17]. Several injury traits had
an association with the magnitude of 48-hour postinjury
HC. Our study shows that as ISS increased there was a
tendency for greater HC. Although this was statistically
significant, it is clear there was individual variability. In
particular, it is important to note that the ISS ≥ 20-
&-TC ≥ 90 mg/dL demonstrated no variation of TC
with ISS. However, the other group showed a highly sig-
nificant inverse relationship between TC and ISS.
Patients with chest injury, shock, or those requiring
RBC transfusion had greater HC than those without
Figure 1 The relationship between 48-hour total cholesterol and Injury Severity Score. The ISS ≥ 20-&-TC ≥ 90 mg/dL - Yes group (boxes)
shows no statistical relationship between cholesterol and Injury Severity Score (r = -0.07; p = 0.55). The ISS ≥ 20-&-TC ≥ 90 mg/dL - No group
(diamonds) demonstrates an inverse correlation between cholesterol and Injury Severity Score (r = -0.53; p < 0.0001).
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these conditions. Although patients with brain injury
had HC, it was less severe than for those without brain
injury. We are not aware of any study that describes the
influence of these traits on TC levels in trauma patients.
In a prospective study of critically ill surgical patients,
Gordon [18] found that patients with neurologic condi-
tions had markedly less HC in comparison to those
without brain pathology. The Gordon manuscript indi-
cates that most patients with neurologic surgical condi-
tions were receiving phenytoin, which may account for
the diminution of HC. Investigations have demonstrated
that phenytoin can increase TC values; [12,13] however,
the study time-frame was typically several weeks [12].
Phenytoin is an inducer of the cytochrome P450 enzyme
system [12] and this enzymatic milieu plays an impor-
tant role in cholesterol balance [19]. Opinions in the lit-
erature suggest that cytochrome P450 induction is not
likely for several days or weeks and is, in part, related to
a drug’s half-life [13,20]. Further, acute inflammation
(release of cytokines) likely inhibits cytochrome P450
metabolism [20]. Based on the short time from pheny-
toin loading until obtaining the 48-hour TC value, cyto-
chrome P450 induction seems improbable. Additionally,
the fact this occurs during acute, severe injury with sys-
temic inflammation also decreases the likelihood of
cytochrome P450 induction. The multivariate analysis of
phenytoin and brain injury effect on 48-hour TC
strongly indicates that phenytoin did not influence TC
values.
For patients developing late VAP, we reviewed all TC
values throughout their ICU course. Following the 48-
hour postinjury TC assessment, patients with late VAP
had a subsequent further decrease in TC. This is consis-
tent with our previous documentation [11] and that of
other investigators who find HC with infectious compli-
cations [10,16,21,22]. After this TC nadir, resolution of
late VAP showed an improvement in HC with a signifi-
cant increase in TC. Again, we previously demonstrated
this proclivity toward resolution of HC with clinical sta-
bilization [11]. Alvarez [23] and Stachon [24] also pro-
vide evidence that HC improves with patient
stabilization following infection and major surgery.
HC is typical following traumatic, surgical, and infectious
injury
After combining and critically reviewing an expanding
literature, there is an impression that HC is the conven-
tional, if not universal, human response to severe
trauma, [10,11,15-17] surgery, [18,24-26] infection,
[10,11,16,21,22] and critical illness [27]. It is also note-
worthy the degree of HC has been shown to correlate
with death in ICU, [27] general surgical, [25,26] trauma,
[16] and cardiothoracic surgical [24] patients. It is also
compelling that patients with resolution of infection and
discharged alive from the ICU have been shown to have
a significant improvement in HC [11,24]. However,
dying patients were found to have persistent HC [11,24].
There is growing evidence that HC is a manifestation of
systemic inflammatory up-regulation. Apropos, studies
have provided data documenting a relationship between
HC and systemic inflammatory mediators and markers
[18,21,24].
Postinjury inflammation may be adaptive or maladaptive
Substantial evidence exists that major injury leads to
systemic inflammatory up-regulation [28-30]. Following
postinjury systemic inflammatory up-regulation, an anti-
inflammatory response typically ensues [28,31]. Such
postinjury systemic inflammatory responses are typically
adaptive [29,30]. However, the response may be mala-
daptive, leading to organ failure, infection, and death
[7-9,29].
Literature evidence suggests that the degree of HC
and systemic inflammation tends to increase with the
severity of traumatic injury [31-33] and surgical illness
[18,34]. The current study demonstrates a significant,
but weak, inverse relationship between TC and ISS and
a relatively large TC standard deviation with ISS ≥ 30
patients. These findings indicate that TC may not routi-
nely decrease with greater injury severity. An attenua-
tion of postinjury HC, relative to an increasing ISS,
appears to be a maladaptive, unexpected host response.
The increase in late VAP, death, and duration of
mechanical ventilation with ISS ≥ 20-&-TC ≥ 90 mg/dL
supports this notion.
Study limitations
Several methodological limitations need consideration.
Although this is a retrospective study, this is an analysis
of consecutive trauma patients requiring emergency tra-
cheal intubation and we consider the trauma registry to
be a reliable database. However, data accuracy and qual-
ity from a retrospective, database source are recognized
to be lower when compared to a prospective, dedicated
database. Debate regarding the diagnosis of VAP is con-
troversial. Some investigators have found similarities
between clinical and bronchoalveolar lavage criteria
[35-37]. Whereas, others believe quantitative lavage is
the superior technique [38]. It is noteworthy that several
other trauma investigators found a VAP rate similar to
that of the current study [2-5]. Of importance, by using
our clinical VAP definition, we portend a subset of
patients with substantially greater ventilator dependency,
a finding noted by several other investigators. We did
not document patients with a pre-injury diagnosis of
hypercholesterolemia and/or receiving cholesterol-lower-
ing medications that might influence 48-hour TC. The
lower TC values for patients with RBC transfusion
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suggest that resuscitation and plasma volume expansion
(dilution) may have influenced TC levels. The failure to
assess the impact of initial fluid volumes on 48-hour TC
is a study weakness.
Conclusions
The current study describes consecutive, trauma patients
needing emergency tracheal intubation who had severe
injury and compelling, subsequent hypocholesterolemia.
Patients with chest injury, shock, and RBC transfusion
had a greater degree of hypocholesterolemia than those
without these entities. On the other hand, brain injury,
which also produced hypocholesterolemia, had a relative
increase in TC in comparison to those without brain
injury. We found that late VAP substantially increased
duration of mechanical ventilation. Of the numerous
potential early risk factors for adverse outcomes (late
VAP, death, and duration of mechanical ventilation),
only ISS ≥ 20-&-TC ≥ 90 mg/dL consistently had an
association. The lack of an association of the many early
risk factors with adverse outcomes, yet the finding that
ISS ≥ 20-&-TC ≥ 90 mg/dL had significant independent
correlations, suggests this is not a fortuitous finding. ISS
≥ 20-&-TC ≥ 90 mg/dL implies that patients with this
characteristic have an increasing ISS and a disproportion-
ate increase in TC. In other words, these patients appear
to have an attenuated postinjury hypocholesterolemia
response. The above observations imply that attenuation
of hypocholesterolemia after severe injury may be a mala-
daptive host response and signals risk for subsequent late
VAP, ventilator dependency, and death.
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